The company will work with researchers from the University of North Texas Health Science Center to develop better software for forensics.
Stat News examines ethical questions raised by Alphabet's Verily awarding a research contract to a clinic mostly owned by its CEO.
Genomics England has selected WuXi Nextcode to interpret genomic data from cancer and rare disease samples as part of the UK 100K Genomes Project.
Congenica and Omicia have signed contracts to interpret data from the first 8,000 patients in the UK's 100,000 Genomes Project.
CDI Laboratories will use Arrayjet's Ultra Marathon II instrument to print its proteomics and other custom microarrays.
N-of-One will provide clinical interpretation services for genomic tests conducted as part of the New England Veterans' Integrated Service Network oncology program
Helomics' tumor profiling products and services, including ChemoFx, will be available to more than 700,000 Prime Health Services providers.
Cologuard will be available to Aetna's Medicare Advantage members through their physician without a co-payment or co-insurance.
The agreement follows a pilot study, under which around 500 Aetna employees participated in Newtopia's personalized health program.
The contract is to further the company's work to develop methodologies aimed at Francisella tularensis, Escherichia coli, and Babesia microti.
Startup companies are taking on personalized medicine, CNET reports.
Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.
The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.
In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.